Laura Van Coile

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Decision Making

Physical Activity

Bioinformatics Analysis

Prognostic Factors

Top Venues

PharmacoEconomics

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Annick Meertens, Laura Van Coile, Tijs Van Iseghem, Lieve Brochez, Nick Verhaeghe, Isabelle Hoorens
Cost-of-Illness of Skin Cancer: A Systematic Review. PharmacoEconomics (2024)
Annick Meertens, Laura Van Coile, Tijs Van Iseghem, Lieve Brochez, Nick Verhaeghe, Isabelle Hoorens
Cost-of-Illness of Skin Cancer: A Systematic Review. PharmacoEconomics 42 (7) (2024)
Annick Meertens, Laura Van Coile, Tijs Van Iseghem, Lieve Brochez, Nick Verhaeghe, Isabelle Hoorens
Cost-of-Illness of Skin Cancer: A Systematic Review. PharmacoEconomics 42 (7) (2024)
Laura Van Coile, Lieve Brochez, Evelien Verhaeghe, Barbara Boone, Annick Meertens, Katia Ongenae, Isabelle Hoorens
A critical re-evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults: should we waive this treatment in certain patients? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Laura Van Coile, Lieve Brochez, Evelien Verhaeghe, Barbara Boone, Annick Meertens, Katia Ongenae, Isabelle Hoorens
A critical re-evaluation of Mohs micrographic surgery for a facial basal cell carcinoma in older adults: Should we waive this treatment in certain patients? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Laura Van Coile, Evelien Verhaeghe, Katia Ongenae, Lieve Brochez, Isabelle Hoorens
Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate? The British journal of dermatology 187 (2) (2022)
Laura Van Coile, Evelien Verhaeghe, Katia Ongenae, Lieve Brochez, Isabelle Hoorens
Study protocol of the BASINEL Study: a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons. BMJ open 12 (11) (2022)